About Michael Rubin
Form D filings for Inflammatix from 2020 to 2021 list Michael Rubin as director.
Michael Rubin first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Rubin in the role, so the role may have started earlier or lasted longer.
Inflammatix, Inc.
Director
2020 – 2021 · Sunnyvale, CA
Inflammatix helps emergency teams identify infection type and illness severity from the body's immune response.
Key Colleagues at Startups
The people Michael Rubin works with at each company, as listed on that company's latest Form D.
Inflammatix, Inc. · Form D, Mar 24, 2021
JK
Justin Kao
Director
KB
Kenneth Bahk
Director

Timothy Sweeney
Co-Founder and CEO, director

Steven Tablak
Former Chairman and CEO, GeneWeave

David Persing
EVP/Chief Medical Officer, Cepheid and director